Contribution of the extracellular cAMP-adenosine pathway to dual coupling of β 2-adrenoceptors to G s and G i proteins in mouse skeletal muscle

Journal of Pharmacology and Experimental Therapeutics

Volumn 341, Issue 3, 2012, Pages 820-828

  Duarte, Thiago ^a   Menezes Rodrigues, Francisco Sandro ^a   Godinho, Rosely Oliveira ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ALPHA,BETA METHYLENEADENOSINE DIPHOSPHATE; BETA 2 ADRENERGIC RECEPTOR; CLENBUTEROL; CYCLIC AMP; FENOTEROL; FORSKOLIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; PERTUSSIS TOXIN; PROBENECID; ROLIPRAM; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAPHRAGM MUSCLE; ELECTROSTIMULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; INOTROPISM; MALE; MOUSE; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ADENOSINE; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ADRENERGIC BETA-AGONISTS; ANIMALS; CLENBUTEROL; CYCLIC AMP; DIAPHRAGM; ELECTRIC STIMULATION; FEEDBACK, PHYSIOLOGICAL; FENOTEROL; FORSKOLIN; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; MALE; MICE; MUSCLE CONTRACTION; RECEPTORS, ADRENERGIC, BETA-2; ROLIPRAM; SIGNAL TRANSDUCTION;

EID: 84861543052     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.192997     Document Type: Article

References (60)

1. Andrade-Lopes AL, Pires-Oliveira M, Menezes-Rodrigues FS, and Godinho RO (2011) Functional characterization of heterotrimeric G-proteins in rat diaphragm muscle. Respir Physiol Neurobiol 175:212-219.
2. Bergantin LB, Figueiredo LB, and Godinho RO (2011) The lumbrical muscle: a novel in situ system to evaluate adult skeletal muscle proteolysis and anticatabolic drugs for therapeutic purposes. J Appl Physiol 111:1710-1718.
3. Biondi C, Ferretti ME, Lunghi L, Medici S, Cervellati F, Pavan B, Vesce F, Morano D, Adinolfi E, Bertoni F, et al. (2010) cAMP efflux from human trophoblast cell lines: a role for multidrug resistance protein (MRP)1 transporter. Mol Hum Reprod 16:481-491.
4. Bowman WC and Nott MW (1969) Actions of sympathomimetic amines and their antagonists on skeletal muscle. Pharmacol Rev 21:27-72.
5. Bünemann M, Lee KB, Pals-Rylaarsdam R, Roseberry AG, and Hosey MM (1999) Desensitization of G-protein-coupled receptors in the cardiovascular system. Annu Rev Physiol 61:169-192. (Pubitemid 29143168)
6. Cairns SP and Dulhunty AF (1993) Beta-adrenergic potentiation of E-C coupling increases force in rat skeletal muscle. Muscle Nerve 16:1317-1325.
7. sα deficiency in skeletal muscle leads to reduced muscle mass, fiber-type switching, and glucose intolerance without insulin resistance or deficiency. Am J Physiol Cell Physiology 296:C930-C940.
8. Chiavegatti T, Costa VL Jr, Araújo MS, and Godinho RO (2008) Skeletal muscle expresses the extracellular cyclic AMP-adenosine pathway. Br J Pharmacol 153: 1331-1340. (Pubitemid 351415496)
9. i and SRC. Cell Signal 19:1949-1955.
10. Cometti B, Dubey RK, Imthurn B, Jackson EK, and Rosselli M (2003) Oviduct cells express the cyclic AMP-adenosine pathway. Biol Reprod 69:868-875. (Pubitemid 37064615)
11. 2-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive g protein. Circulation 100:2210-2212.
12. 2-adrenergic receptor to different G proteins by protein kinase A. Nature 390: 88-91.
13. Dobson JG, Ordway RW, and Fenton RA (1986) Endogenous adenosine inhibits catecholamine contractile responses in normoxic hearts. Am J Physiol Heart Circ Physiol 251:H455-H462.
14. Du L, Gao ZG, Nithipatikom K, Ijzerman AP, Veldhoven JP, Jacobson KA, Gross GJ, and Auchampach JA (2012) Protection from myocardial ischemia/reperfusion injury by a positive allosteric modulator of the A3 adenosine receptor. J Pharmacol Exp Ther 340:210-217.
15. Dubey RK, Gillespie DG, Mi Z, and Jackson EK (2001) Endogenous cyclic AMPadenosine pathway regulates cardiac fibroblast growth. Hypertension 37:1095-1100. (Pubitemid 32304010)
16. Dubey RK, Mi Z, Gillespie DG, and Jackson EK (1996) Cyclic AMP-adenosine pathway inhibits vascular smooth muscle cell growth. Hypertension 28:765-771. (Pubitemid 26365516)
17. Dubey RK, Rosselli M, Gillespie DG, Mi Z, and Jackson EK (2010) Extracellular 3′,5′-cAMP-adenosine pathway inhibits glomerular mesangial cell growth. J Pharmacol Exp Ther 333:808-815.
18. Easton PA, Katagiri M, Johnson MW, Rothwell BC, Holroyde MC, and Kusuhara N (2008) Effect of salbutamol on respiratory muscle function and ventilation in awake canines. Respir Physiol Neurobiol 161:253-260. (Pubitemid 351645131)
19. L-2-phenylisopropyl)adenosine and insulin on cAMP metabolism in 3T3-L1 adipocytes. Am J Physiol 252:C342-C348.
20. Ferguson SS, Zhang J, Barak LS, and Caron MG (1998) Molecular mechanisms of G protein-coupled receptor desensitization and resensitization. Life Sci 62:1561-1565. (Pubitemid 28210241)
21. 1receptors in intact DDT1 MF-2 smooth muscle cells. Mol Pharmacol 38:660-666.
22. Giron MC, Bin A, Brun P, Etteri S, Bolego C, Florio C, and Gaion RM (2008) Cyclic AMP in rat ileum: evidence for the presence of an extracellular cyclic AMPadenosine pathway. Gastroenterology 134:1116-1126. (Pubitemid 351451977)
23. 2+ in muscle cell damage. Ann NY Acad Sci 1066: 166-180.
24. Godinho RO and Costa VL Jr (2003) Regulation of intracellular cyclic AMP in skeletal muscle cells involves the efflux of cyclic nucleotide to the extracellular compartment. Br J Pharmacol 138:995-1003. (Pubitemid 36390657)
25. Gosmanov AR, Wong JA, and Thomason DB (2002) Duality of G protein-coupled mechanisms for β-adrenergic activation of NKCC activity in skeletal muscle. Am J Physiol Cell Physiology 283:C1025-C1032.
26. i proteins. Br J Pharmacol 138:1358-1366.
27. Hellsten Y and Frandsen U (1997) Adenosine formation in contracting primary rat skeletal muscle cells and endothelial cells in culture. J Physiol 504:695-704. (Pubitemid 27493866)
28. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
29. Hespel P and Richter EA (1998) Role of adenosine in regulation of carbohydrate metabolism in contracting muscle. Adv Exp Med Biol 441:97-106. (Pubitemid 28428983)
30. Hofer AM and Lefkimmiatis K (2007) Extracellular calcium and cAMP: second messengers as "third messengers"? Physiology 22:320-327.
31. Jackson EK and Raghvendra DK (2004) The extracellular cyclic AMP-adenosine pathway in renal physiology. Annu Rev Physiol 66:571-599. (Pubitemid 40614455)
32. i. Circ Res 87:705-709.
33. Knauer MJ, Urquhart BL, Meyer zu Schwabedissen HE, Schwarz UI, Lemke CJ, Leake BF, Kim RB, and Tirona RG (2010) Human skeletal muscle drug transporters determine local exposure and toxicity of statins. Circ Res 106:297-306.
34. 2-adrenergic signaling. J Biol Chem 274:22048-22052.
35. LaMonica DA, Frohloff N, and Dobson JG Jr (1985) Adenosine inhibition of catecholamine-stimulated cardiac membrane adenylate cyclase. Am J Physiol 248: H737-H744. (Pubitemid 15027176)
36. 2 adrenoceptor coupling to Gi proteins in cardiomyocytes. J Biol Chem 284:32279-32287.
37. Lynch GS and Ryall JG (2008) Role of β-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease. Physiol Rev 88:729-767. (Pubitemid 351520091)
38. Lynge J and Hellsten Y (2000) Distribution of adenosine A1, A2A and A2B receptors in human skeletal muscle. Acta Physiol Scand 169:283-290.
39. Lynge J, Juel C, and Hellsten Y (2001) Extracellular formation and uptake of adenosine during skeletal muscle contraction in the rat: role of adenosine transporters. J Physiol 537:597-605. (Pubitemid 33130513)
40. 2-adrenoceptor-independent mechanism. J Appl Physiol 109:1716-1727.
41. 2-adrenoceptor-mediated glucose uptake in rat skeletal muscle cells. Br J Pharmacol 147:446-454.
42. Ottenheijm CA, Heunks LM, and Dekhuijzen PN (2007) Diaphragm muscle fiber dysfunction in chronic obstructive pulmonary disease: toward a pathophysiological concept. Am J Resp Crit Care Med 175:1233-1240. (Pubitemid 46905747)
43. Reading SA and Barclay JK (2001) A1 receptor activation decreases fatigue in mammalian slow-twitch skeletal muscle in vitro. Can J Physiol Pharmacol 79:496-501. (Pubitemid 32745046)
44. Reiken S, Lacampagne A, Zhou H, Kherani A, Lehnart SE, Ward C, Huang F, Gaburjakova M, Gaburjakova J, Rosemblit N, et al. (2003) PKA phosphorylation activates the calcium release channel (ryanodine receptor) in skeletal muscle: defective regulation in heart failure. J Cell Biol 160:919-928. (Pubitemid 36350846)
45. Reinecke D, Burhenne H, Sandner P, Kaever V, and Seifert R (2011) Human cyclic nucleotide phosphodiesterases possess a much broader substrate- specificity than previously appreciated. FEBS Lett 585:3259-3262.
46. Ren H and Stiles GL (1994) Characterization of the human A1 adenosine receptor gene. Evidence for alternative splicing. J Biol Chem 269:3104-3110.
47. Safran N, Shneyvays V, Balas N, Jacobson KA, Nawrath H, and Shainberg A (2001) Cardioprotective effects of adenosine A1 and A3 receptor activation during hypoxia in isolated rat cardiac myocytes. Mol Cell Biochem 217:143-152. (Pubitemid 32184467)
48. Sager G and Ravna AW (2009) Cellular efflux of cAMP and cGMP-a question about selectivity. Mini Rev Med Chem 9:1009-1013.
49. Souccar C, Gonçalo Mdo C, Buck Hde S, Lima-Landman MT, and Lapa AJ (2005) Mild dystrophic damage in the androgen-sensitive levator ani muscle of the mdx mouse. Neuromusc Disord 15:48-56. (Pubitemid 41556633)
50. Strouch MB, Jackson EK, Mi Z, Metes NA, and Carey GB (2005) Extracellular cyclic AMP-adenosine pathway in isolated adipocytes and adipose tissue. Obes Res 13:974-981.
51. Thong FS, Lally JS, Dyck DJ, Greer F, Bonen A, and Graham TE (2007) Activation of the A1 adenosine receptor increases insulin-stimulated glucose transport in isolated rat soleus muscle. Appl Physiol Nutr Metab 32:701-710.
52. Van Der Heijden HF, Zhan WZ, Prakash YS, Dekhuijzen PN, and Sieck GC (1998) Salbutamol enhances isotonic contractile properties of rat diaphragm muscle. J Appl Physiol 85:525-529. (Pubitemid 28365820)
53. 2+-induced disruption of excitation-contraction coupling in mammalian skeletal muscle fibers. Am J Physiol Cell Physiol 296:C1115-C1122.
54. Verrier JD, Exo JL, Jackson TC, Ren J, Gillespie DG, Dubey RK, Kochanek PM, and Jackson EK (2011) Expression of the 2′,3′-cAMP-adenosine pathway in astrocytes and microglia. J Neurochem 118:979-987.
55. i-mediated counterregulation in transgenic mice overexpressing type 5 adenylyl cyclase. Am J Physiol Lung Cell Mol Physiol 300:L472-L478.
56. i/o protein/nitric oxide-coupled pathway. Hypertension 54:157-163.
57. q-proteins. Mol Pharmacol 58:954-966.
58. Whalen EJ, Rajagopal S, and Lefkowitz RJ (2011) Therapeutic potential of β-arrestin- and G protein-biased agonists. Trends Mol Med 17:126-139.
59. 2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes. Circ Res 84:43-52.
60. Zheng J, Wang R, Zambraski E, Wu D, Jacobson KA, and Liang BT (2007) Protective roles of adenosine A1, A2A, and A3 receptors in skeletal muscle ischemia and reperfusion injury. Am J Physiol Heart Circ Physiol 293:H3685-H3691. (Pubitemid 350230914)